Clinical trials: Patients With Anorexia Nervosa
Eating Disorder
Impact of Neuropsychological Alteration of Decision-making Abilities on the Functioning of Patients With Eating Disorders
Eating disorders are multifactorial disorders currently conceptualized in a biopsychosocial model, but pathophysiology remains relatively unknown, and robust etiological models to guide treatment are therefore lacking.
- Trial name
- NEUROPSY_TCA (NCT03160443)
- Testing
- Ambulatory cares in a day-hospital (University Hospital of Montpellier) specialized in the evaluation of eating disorders
- Where
- France
- Volunteers
- 340 people
- Sponsor
- University Hospital, Montpellier
Anorexia Nervosa
Energy Turnover in Patients With Anorexia Nervosa
Pilot study to assess energy turnover at end of inpatient treatment in 10 patients with Anorexia nervosa.
- Trial name
- NCT03151135
- Where
- Germany
- Volunteers
- 5 people
- Sponsor
- Charite University, Berlin, Germany
Patients With Anorexia Nervosa
Bone Loss in Patients With Anorexia Nervosa
Nutritional deprivation of adolescent girls with anorexia nervosa (AN) reduces the bone mass acquisition. A better understanding of this process would improve the medical treatment of bone alteration and its long-term…
- Trial name
- NCT01907464
- Testing
- clinical parameters description, para clinical parameters description, hormonal parameters dosing
- Where
- France
- Volunteers
- 320 people, healthy volunteers welcome
- Sponsor
- University Hospital, Montpellier
Anorexia Nervosa, Appetite Disorders
Hunger and Satiety in Anorexia Nervosa
Anorexia means loss of appetite. But there is disagreement about whether the appetite is changed by the disease anorexia nervosa (AN).
- Trial name
- HUSAAN (NCT02932046)
- Testing
- Standardized noon meal
- Where
- Denmark
- Volunteers
- 47 people
- Sponsor
- Odense University Hospital
Anorexia Nervosa, Feeding and Eating Disorders of Childhood
Facilitators and Barriers in Anorexia Nervosa - Treatment Initiation
Anorexia nervosa (AN) is a comparably low-prevalent illness. Chronic courses are often and the mortality rate of patients with AN is higher than in any other mental illness.
- Trial name
- FABIANA (NCT03713541)
- Testing
- No intervention
- Where
- 18 sites in Germany
- Volunteers
- 450 people
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf
Anorexia Nervosa with Significantly Low Body Weight
Comparing Olanzapine and Mirtazapine in the Improvement of Unintentional Weight Loss for Patients with Advanced Stage Cancer
To determine whether olanzapine or mirtazapine is more effective in preventing weight loss and appetite loss in cancer patients.
- Trial name
- NCT05170919
- Testing
- Mirtazapine, Olanzapine
- Where
- United States
- Volunteers
- 170 people
- Sponsor
- Englewood Hospital and Medical Center
Feeding and Eating Disorders
Italian Validation of the State Urge to be Physically Active- Questionnaire (SUPAQ-I) in Patients With Eating Disorders
Eating disorders (EDs) are severe psychiatric conditions that cause significant health and psychosocial issues, with Anorexia Nervosa (AN) and Bulimia Nervosa (BN) having the highest mortality rates.
- Trial name
- SUPAQ-I (NCT06514456)
- Testing
- no intervention
- Where
- Italy
- Volunteers
- 210 people
- Sponsor
- Istituto Auxologico Italiano
Anorexia Nervosa
Olanzapine in the Treatment of Patients With Anorexia Nervosa
The purpose of the study is to evaluate the efficacy of an anti-psychotic medication, Olanzapine, in achieving desired weight gain in patients identified as having Anorexia Nervosa, either restricting or binge/purge subtype.
- Trial name
- NCT00260962
- Testing
- Olanzapine, Day Hospital
- Where
- Canada
- Volunteers
- 34 people
- Sponsor
- Ottawa Hospital Research Institute
Anxiety in Those Patients With Anorexia Nervosa, Eating Disorder Not Otherwise Specified, BMI (<=18)
Does Hydroxyzine Decrease Anxiety in Underweight Patients Diagnosed With an Eating Disorder
The purpose of this study is to determine the effectiveness of hydroxyzine in the treatment of meal-related anxiety in adolescents and young adults 8 to 25 years of age diagnosed with an eating disorder who are underweight.
- Trial name
- NCT01372670
- Testing
- Hydroxyzine, hydroxyzine HCL
- Where
- United States
- Sponsor
- HealthPartners Institute
Anorexia Nervosa
Liver Biomarkers in Anorexia Nervosa
The main goal of the Liver Biomarkers in Anorexia Nervosa (LIBAN) study is to determine the prevalence of liver fibrosis in patient with Anorexia Nervosa.
- Trial name
- LIBAN (NCT05861375)
- Testing
- Fibroscan
- Where
- France
- Volunteers
- 43 people
- Sponsor
- Nantes University Hospital
Anorexia Nervosa
Exploring Clinical Study Experiences of People With Anorexia Nervosa
The study seeks to delve into the firsthand experiences of patients diagnosed with anorexia nervosa who partake in a separate clinical trial featuring a specific medical intervention.
- Trial name
- NCT06207890
- Where
- United States
- Volunteers
- 500 people
- Sponsor
- Power Life Sciences Inc.
Eating Disorders, Anorexia Nervosa
Inpatient Care of Patients With Difficult to Treat Anorexia Nervosa - Factors Affecting Treatment Outcome.
The overall aim of the project is to investigate factors that may influence treatment outcomes in people with difficult-to-treat anorexia nervosa who are enrolled in inpatient care at the Region Skåne Eating Disorders Centre in…
- Trial name
- NCT07350720
- Volunteers
- 100 people
- Sponsor
- Region Skane
Anorexia Nervosa, Kidney Injury
Kidney Function and Anorexia Nervosa
Anorexia nervosa (AN) is an eating disorder that can lead to severe medical complications. Kidney injuries are unknown in patients with extremely malnourished AN (BMI <13).
- Trial name
- ANKID (NCT05327998)
- Where
- France
- Volunteers
- 30 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Anorexia Nervosa, Obesity
The Effects of Dietary Intervention on Gastrointestinal Function in Patients With Anorexia Nervosa and Obesity
Diseases characterized by abnormal low and high body weight are common in the community and are associated with significant morbidity, mortality and health care related costs.
- Conditions
- Anorexia Nervosa, Obesity, Healthy Participants
- Trial name
- NCT00946816
- Testing
- Nutritional Intervention
- Where
- Switzerland
- Volunteers
- 60 people
- Sponsor
- University of Zurich
Anorexia Nervosa, Bulimia Nervosa
Studies of Neuroendocrine and Energy Metabolism in Patients With Eating Disorders
This study aims to investigate neuroendocrine, autonomic functioning, and energy metabolism in patients with eating disorder and their relationships with psychopathology of eating disorders (eating patterns, depression, and…
- Trial name
- NCT00631605
- Where
- Taiwan
- Volunteers
- 112 people, healthy volunteers welcome
- Sponsor
- National Taiwan University Hospital
Anorexia Nervosa, Health-Related Quality Of Life
Health Related Quality of Life for Patients With Anorexia Nervosa in Denmark.
Eating disorders (ED) comprise a multitude of symptoms involving a disturbed body image and a preoccupation with food or bodyweight. EDs are often difficult to treat, in part due to the lack of motivation for improvement.
- Trial name
- QOLAN-DK (NCT03230435)
- Testing
- Treatment settings as usual.
- Where
- Denmark
- Volunteers
- 496 people, healthy volunteers welcome
- Sponsor
- René Klinkby Støving